[go: up one dir, main page]

IT1299069B1 - Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps") - Google Patents

Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")

Info

Publication number
IT1299069B1
IT1299069B1 IT98MI000774A ITMI980774A IT1299069B1 IT 1299069 B1 IT1299069 B1 IT 1299069B1 IT 98MI000774 A IT98MI000774 A IT 98MI000774A IT MI980774 A ITMI980774 A IT MI980774A IT 1299069 B1 IT1299069 B1 IT 1299069B1
Authority
IT
Italy
Prior art keywords
pain syndrome
regional pain
chronic regional
crps
treatment
Prior art date
Application number
IT98MI000774A
Other languages
English (en)
Inventor
Massimo Spriano
Menotti Calvani
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT98MI000774A priority Critical patent/IT1299069B1/it
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to PCT/IT1999/000084 priority patent/WO1999052517A2/en
Priority to DK99916036T priority patent/DK0994703T3/da
Priority to AU34426/99A priority patent/AU742013B2/en
Priority to HK00103475.8A priority patent/HK1026608B/en
Priority to BR9906350-6A priority patent/BR9906350A/pt
Priority to ES99916036T priority patent/ES2203115T3/es
Priority to NZ501416A priority patent/NZ501416A/en
Priority to PT99916036T priority patent/PT994703E/pt
Priority to KR1019997011697A priority patent/KR100573010B1/ko
Priority to CA002292638A priority patent/CA2292638C/en
Priority to IL133141A priority patent/IL133141A/en
Priority to DE69909395T priority patent/DE69909395T2/de
Priority to AT99916036T priority patent/ATE244566T1/de
Priority to SI9930359T priority patent/SI0994703T1/xx
Priority to EP99916036A priority patent/EP0994703B1/en
Priority to JP55145199A priority patent/JP4482163B2/ja
Publication of ITMI980774A1 publication Critical patent/ITMI980774A1/it
Priority to US09/458,966 priority patent/US6214884B1/en
Application granted granted Critical
Publication of IT1299069B1 publication Critical patent/IT1299069B1/it
Priority to US10/423,971 priority patent/US20040209906A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
IT98MI000774A 1998-04-10 1998-04-10 Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps") IT1299069B1 (it)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IT98MI000774A IT1299069B1 (it) 1998-04-10 1998-04-10 Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")
DE69909395T DE69909395T2 (de) 1998-04-10 1999-04-08 Zusammensetzung mit ketanserin und carnitin zur behandlung von crps
AU34426/99A AU742013B2 (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and L-carnitine or an alkanoyl L-carnitine for the treatment of CRPS
HK00103475.8A HK1026608B (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and l-carnitine for the treatment of crps
BR9906350-6A BR9906350A (pt) 1998-04-10 1999-04-08 Composição contendo cetanserina e l-carnitina ou uma alcanoil l-carnitina para o tratamento de crps
ES99916036T ES2203115T3 (es) 1998-04-10 1999-04-08 Composicion que comprende ketanserina y l-carnitina para el tratamiento del sindrome de dolor local cronico.
NZ501416A NZ501416A (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and L-carnitine or an alkanoyl L-carnitine for the treatment of CRPS
PT99916036T PT994703E (pt) 1998-04-10 1999-04-08 Composicao compreendendo ketanserina e l-carnitina para o tratamento de sdrc
PCT/IT1999/000084 WO1999052517A2 (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and l-carnitine or an alkanoyl l-carnitine for the treatment of crps
CA002292638A CA2292638C (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and l-carnitine or an alkanoyl l-carnitine for the treatment of crps
IL133141A IL133141A (en) 1998-04-10 1999-04-08 A composition containing catechins and L-carnitine for the treatment of CRPS
DK99916036T DK0994703T3 (da) 1998-04-10 1999-04-08 Sammensætning omfattende ketanserin og L-carnitin til behandlingen af CRPS
AT99916036T ATE244566T1 (de) 1998-04-10 1999-04-08 Zusammensetzung mit ketanserin und carnitin zur behandlung von crps
SI9930359T SI0994703T1 (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and l-carnitine for the treatment of crps
EP99916036A EP0994703B1 (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and l-carnitine for the treatment of crps
JP55145199A JP4482163B2 (ja) 1998-04-10 1999-04-08 ケタンセリンとｌ−カルニチン又はアルカノイルｌ−カルニチンを含むｃｒｐｓの治療のための組成物
KR1019997011697A KR100573010B1 (ko) 1998-04-10 1999-04-08 케탄제린 및 ｌ-카르니틴 또는 알카노일 ｌ-카르니틴을함유하는 ｃｒｐｓ 치료용 조성물
US09/458,966 US6214884B1 (en) 1998-04-10 1999-12-10 Composition comprising ketanserin and L-carnitine or an alkanoyl L-carnitine for the treatment of CRPS
US10/423,971 US20040209906A1 (en) 1998-04-10 2003-04-28 Composition comprising ketanserin AND AN ALKANOYL L-CARNITINE FOR THE TREATMENT OF CRPS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98MI000774A IT1299069B1 (it) 1998-04-10 1998-04-10 Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")

Publications (2)

Publication Number Publication Date
ITMI980774A1 ITMI980774A1 (it) 1999-10-10
IT1299069B1 true IT1299069B1 (it) 2000-02-07

Family

ID=11379743

Family Applications (1)

Application Number Title Priority Date Filing Date
IT98MI000774A IT1299069B1 (it) 1998-04-10 1998-04-10 Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")

Country Status (16)

Country Link
US (2) US6214884B1 (it)
EP (1) EP0994703B1 (it)
JP (1) JP4482163B2 (it)
KR (1) KR100573010B1 (it)
AT (1) ATE244566T1 (it)
AU (1) AU742013B2 (it)
BR (1) BR9906350A (it)
CA (1) CA2292638C (it)
DE (1) DE69909395T2 (it)
DK (1) DK0994703T3 (it)
ES (1) ES2203115T3 (it)
IL (1) IL133141A (it)
IT (1) IT1299069B1 (it)
NZ (1) NZ501416A (it)
PT (1) PT994703E (it)
WO (1) WO1999052517A2 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004084905A2 (en) * 2003-03-24 2004-10-07 University Of Florida Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CN1686139B (zh) * 2005-04-30 2012-07-11 福建师范大学 酮色林在治疗炎性疼痛的新型镇痛药中的应用
KR20240100931A (ko) 2022-12-23 2024-07-02 주식회사 일리아스바이오로직스 슈퍼-리프레서(super-repressor, SR)-IκB(srIκB)를 포함하는 엑소좀의 복합부위통증증후군에 대한 치료적 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973004A (en) * 1997-04-04 1999-10-26 Howard; James R. L-carnitine, acetyl-L-carnitine, and pantothenic acid or ubiquinone, combined for prevention and treatment of syndromes related to ineffective energy metabolism

Also Published As

Publication number Publication date
EP0994703A2 (en) 2000-04-26
AU3442699A (en) 1999-11-01
CA2292638A1 (en) 1999-10-21
WO1999052517A3 (en) 2000-01-06
IL133141A (en) 2006-06-11
NZ501416A (en) 2002-03-01
DE69909395D1 (de) 2003-08-14
KR20010013685A (ko) 2001-02-26
ITMI980774A1 (it) 1999-10-10
AU742013B2 (en) 2001-12-13
ATE244566T1 (de) 2003-07-15
WO1999052517A2 (en) 1999-10-21
IL133141A0 (en) 2001-03-19
US20040209906A1 (en) 2004-10-21
HK1026608A1 (en) 2000-12-22
EP0994703B1 (en) 2003-07-09
CA2292638C (en) 2008-08-26
US6214884B1 (en) 2001-04-10
DE69909395T2 (de) 2004-06-09
PT994703E (pt) 2003-11-28
ES2203115T3 (es) 2004-04-01
JP2002504934A (ja) 2002-02-12
DK0994703T3 (da) 2003-11-03
KR100573010B1 (ko) 2006-04-24
JP4482163B2 (ja) 2010-06-16
BR9906350A (pt) 2000-09-19

Similar Documents

Publication Publication Date Title
MY132705A (en) Novel compounds with analgesic effect
CA2274074A1 (en) Novel compounds with analgesic effect
NO308854B1 (no) Terapeutiske forbindelser, farmasøytisk akseptable salter og formuleringer inneholdende forbindelsene, samt anvendelser derav
NO20053104D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
EE04002B1 (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja antatsiidainet või alginaati
EP0513702A3 (en) Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication
CA2344407A1 (en) Method for the treatment of mania and bipolar disorder
GB2320431B (en) Compositions for the treatment of chronic wounds
IL115589A0 (en) Use of cck-b antagonists in pharmaceutical compositions
IT1283951B1 (it) Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
GR3015431T3 (en) Use of acetyl L-carnitine in the therapeutic treatment of coma.
BG102342A (en) Optical active derivative of phenylpyrimidine as an anlgesics
IT1299069B1 (it) Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")
CA2297153A1 (en) Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
AU3600199A (en) A pharmaceutical composition containing ezrin mutated on tyrosine 353
IL127851A0 (en) Inhibition of TNF activity
ITRM950544A0 (it) Uso della l-carnitina di suoi derivati e di loro sali farmaceuticamen-te accettabili in combinazione con farmaci antiretrovirali per ridurrei livelli di ceramide e potenziare l'attivita' di tali farmaci antire-trovirali per il trattamento terapeutico dell'invenzione...
ITMI951649A0 (it) Impiego di composti agonisti o antagonisti dei recettori purinici p2 per la prevenzione della citotossicita' da glutammato
BR9810387A (pt) (s) 3, 4, 5-trimetoxibenzoato de 2-metilamino-2-fenil-n-butila, e sua aplicação para o tratamento de dor crÈnica
IT1265342B1 (it) Composizioni farmaceutiche a base di derivati della glicina
IT1302858B1 (it) Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento avente attivita' antitumorale.
IT1282952B1 (it) Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento della costipazione
MX9701294A (es) Un medicamento que contiene un derivado de carnitina para el tratamiento de la arterioesclerosis cronica obliteradora.
HUP0202145A3 (en) The use of r(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders

Legal Events

Date Code Title Description
0001 Granted